Publications by authors named "Edward Banham Hall"

Claim this Profile
E
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.
Frances C Hall, Joseph Cheriyan, Andrew P Cope, James Galloway, Ian Wilkinson, Edward Banham-Hall

Lancet Respir Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Malcolm Begg, Augustin Amour, Emily Jarvis, Teresa Tang, Sara Santos Franco, Edward Banham Hall

Pulm Pharmacol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Jack A Brown, Joanne Bal, Monica Simeoni, Peter Williams, Palwinder K Mander, Edward J Banham-Hall

Br J Clin Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Admission COVID-19 clinical risk assessment for guiding patient placement and diagnostic testing strategy.
Nick K Jones, Isobel Ramsay, Elinor Moore, Jonathan Fuld, Chris Adcock, Edward Banham-Hall

Clin Med (Lond)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.
Spoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, Edward Banham-Hall, Simon Bond, Frances Hall

Trials· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.
Ing Ni Lu, Spoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, Edward Banham-Hall, Frances Hall

Trials· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell sorting actuated by a microfluidic inertial vortex.
Robyn H Pritchard, Alexander A Zhukov, James N Fullerton, Andrew J Want, Fred Hussain, Edward Banham-Hall

Lab Chip· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals.
Robert Wilson, Alison Templeton, Claudia Leemereise, Rhena Eames, Edward Banham-Hall

Clin Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hindsight bias critically impacts on clinicians' assessment of care quality in retrospective case note review.
Edward Banham-Hall, Sian Stevens

Clin Med (Lond)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner.
Anne-Katrien Stark, Anita Chandra, Krishnendu Chakraborty, Rafeah Alam, Valentina Carbonaro, Edward Banham-Hall

Nat Commun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reviewing post-discharge mortality improves morbidity and mortality processes for patients with a general medical hospital admission.
Edward Banham-Hall, Mark Jeffrey, Ewen Cameron, Tim Burton, Andrew Fry

Clin Med (Lond)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.
Ivan Angulo, Oscar Vadas, Fabien Garçon, Edward Banham-Hall, Vincent Plagnol

Science· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.
Edward Banham-Hall, Menna R Clatworthy, Klaus Okkenhaug

Open Rheumatol J· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poisoning and toxicological emergencies - current trends and practice.
Edward Banham-Hall, Robert Mallinson, Nicola Trepte

Acute Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local thrombolytic therapy for primary axillosubclavian vein thrombosis.
Isabella Maund, Edward Banham-Hall, Robert Mallinson

JRSM Short Rep· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy with unknown primary presenting as acute cardiac tamponade: a case report.
Edward J Banham-Hall, Awais M Bokhari

Cases J· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis